Full Text
Budget Impact Analysis of First-Line Treatment with Branded Pemetrexed (ALIMTA) for Advanced Non-Squamous Non-Small Cell Lung Cancer in China

Abstract

Authors

Q Shi N Rajan P Davey R Davey

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×